Ryuhei So

Ryuhei So

Auto-generated profile, based on publicly available information

Ryuhei So

Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

4 May 2017 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
RSRyuhei So
Ryuhei So
KMKazunori Makino
Kazunori Makino
MFMasaki Fujiwara
Masaki Fujiwara
THTomoya Hirota
Tomoya Hirota
KOKozo Ohcho
Kozo Ohcho
MIMasatoshi Inagaki
Masatoshi Inagaki

1 May 2017 in Schizophrenia Research
Verified
Journal Article
Closed access
GOGiovanni Ostuzzi
Giovanni Ostuzzi
IBIrene Bighelli
Irene Bighelli
RSRyuhei So
Ryuhei So
TFToshi A. Furukawa
Toshi A. Furukawa
CBCorrado Barbui
Corrado Barbui

11 March 2020 in Journal of Gambling Studies
Verified
Journal Article
Closed access
PDF file
RSRyuhei So
Ryuhei So
TFToshi A. Furukawa
Toshi A. Furukawa
SMSachio Matsushita
Sachio Matsushita
TBToshiaki Baba
Toshiaki Baba
TMTakanobu Matsuzaki
Takanobu Matsuzaki
SHSusumu Higuchi
Susumu Higuchi

23 January 2021 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
PDF file
KKKazuomi Kario
Kazuomi Kario
ANAkihiro Nomura
Akihiro Nomura
AKAyaka Kato
Ayaka Kato
NHNoriko Harada
Noriko Harada
TTTomoyuki Tanigawa
Tomoyuki Tanigawa
KSKohta Satake
Kohta Satake
Hypertension is the most considerable but treatable risk factor for cardiovascular disease. Although physicians prescribe multiple antihypertensive drugs and promote lifestyle modifications, the real‐world blood pressure (BP) control rate remains poor. To improve BP target achievement, we developed a novel digital therapeutic—the HERB software system —to manage hypertension. Here, we performed a randomized pilot study to assess the safety and efficacy of the HERB system for hypertension. We recruited 146 patients with essential hypertension from March 2018 to March 2019. We allocated eligible patients to the intervention group (HERB system + standard lifestyle modification) or control group (standard lifestyle modification alone). The primary outcome was the mean change from baseline to 24 weeks in 24‐hour systolic BP (SBP) measured by ambulatory blood pressure monitoring (ABPM). The baseline characteristics in each group were well balanced; the mean age was approx. 57 years, and 67% were male. In the primary end point at 24 weeks, HERB intervention did not lower the mean change of 24‐hour SBP by ABPM compared with the controls (adjusted difference: −0.66 mmHg; p = .78). In an exploratory analysis focusing on antihypertensive drug‐naïve patients aged <65, the effects of the HERB intervention were significantly greater than the control for reducing 24‐hour SBP by ABPM at 16 weeks (adjusted difference: −7.6 mmHg; p = .013; and morning home SBP at 24 weeks (adjusted difference − 6.0 mmHg; p = .012). Thus, the HERB intervention did not achieve a primary efficacy end point. However, we observed that antihypertensive drug‐naïve adult hypertensive patients aged <65 years could be a potential HERB system‐effective target for further investigations of the efficacy of the system.

8 February 2018 in Journal of Medical Internet Research
Verified
Journal Article
Open access
RSRyuhei So
Ryuhei So
KSKiyomi Shinohara
Kiyomi Shinohara
TATakuya Aoki
Takuya Aoki
Yasushi TsujimotoYasushi Tsujimoto
Yasushi Tsujimoto
ASAya M Suganuma
Aya M Suganuma
TFToshi A Furukawa
Toshi A Furukawa
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet